»
Bioorganic & Medicinal Chemistry Letters
 
 

Bioorganic & Medicinal Chemistry Letters

The Tetrahedron Journal for Research at the Interface of Chemistry and Biology

 
 

Journal

 2.486(2015)

2.427

Editor-in-Chief:S. Neidle

Show

0960894X

27

24

Go to Journal Website

Personal Print Journal


Subscription Details

Estimated Delivery Time


In Stock

USD 529.00

eJournal

Subscription Details

ScienceDirect Subscription

  • Access for 5 users
  • Access to 4 years of archives

USD 6,383.20

Print Journal


Subscription Details

Estimated Delivery Time


In Stock

USD 6,382.00
Buying for Institutions
Terms & Conditions

Additional Subscription Help

 
 
 

Aims & Scope

Bioorganic & Medicinal Chemistry Letters publishes research communications of outstanding significance and timeliness on topics at the interface of chemistry and biology, together with invited concise review articles. The journal publishes reports of experimental results in medicinal chemistry, chemical biology and drug discovery and design, emphasizing new and emerging advances and concepts in these fields. The journal continues to be a major forum for the first publication of new chemical entities prior to them entering clinical trials.

The Journal welcomes papers on:

  • the medicinal chemistry and associated biology (including target identification and validation) of established or new disease targets
  • the reporting of the discovery, design or optimization of potent new compounds or biological agents
  • the analysis and discussion of structure-activity relationships and pharmacological issues relevant to drug design and action using in vitro and in vivo models, including the use of computational techniques when closely linked to experimental data
  • the reporting of "first-in-class" new therapeutic compounds
  • the chemical biology or bioorganic/bioinorganic chemistry that significantly advances knowledge of a biological mechanism
  • methodological advances that are chemistry-based and which significantly impact on medicine or biology
  • the preparation and examination of biotherapeutics for the treatment of pathophysiological disease states
  • the development of materials for specific therapeutic targeting

All manuscripts will be rigorously peer-reviewed by independent experts following an initial assessment by the Editors. Please note that BMCL is not suitable for straightforward reports of incremental advances. Above all the presentation of a rational basis and a sound underlying hypothesis for the work is of particular importance, whatever its exact field.

Audience

Chemists, Medicinal Chemists, Pharmacologists, Biochemists, Molecular Biologists.

Abstracting and Indexing

Adis LMS Drug Alerts, BIOSIS, Beilstein Database, Biochemistry and Biophysics Citation Index, CAB Abstracts, CAB Health, Cancerlit, Chemical Abstracts, Chemical Citation Index, Current Contents/Life Sciences, EMBASE, Elsevier BIOBASE/Current Awareness in Biological Sciences, Excerpta Medica, MEDLINE®, Pascal, Research Alert, SCISEARCH, Science Citation Index, Scopus, TOXFILE
Editors D.L. Boger - Editor in Chief The Scripps Research Institute, La Jolla, CA, USA, S. Neidle University College London (UCL), London, UK, M. Shibasaki University of Tokyo, Tokyo, Japan, Editor Digests P.R. Bernstein PharmaB LLC, Philadelphia, PA, USA, Chairman S. Neidle University College London (UCL), London, UK, Editor Emeritus H.H. Wasserman Lexington, MA, USA, Executive Board of Editors for Tetrahedron Publications P.R. Bernstein PharmaB LLC, Philadelphia, PA, USA, D.L. Boger The Scripps Research Institute, La Jolla, CA, USA, S. Chandrasekaran Indian Institute of Science, Bangalore, India, M. Christmann Technische Universität Dortmund, Dortmund, Germany, S.G. Davies University of Oxford, Oxford, UK, L. Ghosez Institut Européen de Chimie et de Biologie (IECB), Pessac, France, Y. Hashimoto University of Tokyo, Tokyo, Japan, T. Hayashi Osaka University, Suita-Shi, Japan, T. Hayashi Institute of Materials Research and Engineering (IMRE), Singapore, K.D. Janda The Scripps Research Institute, La Jolla, CA, USA, M. Kitamura Nagoya University, Nagoya, Japan, G.-Q. Lin Chinese Academy of Sciences (CAS), Shanghai, China, S.F. Martin University of Texas at Austin, Austin, TX, USA, K. Maruoka Kyoto University, Kyoto, Japan, S. Neidle University College London (UCL), London, UK, G.P. Pandey Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGI), Lucknow, India, M. Shibasaki University of Tokyo, Tokyo, Japan, B.M. Stoltz California Institute of Technology, Pasadena, CA, USA, R.J.K. Taylor University of York, York, UK, E.J. Thomas University of Manchester, Manchester, UK, K. Tomioka Doshisa Women's College of Liberal Arts, Kyoto, Japan, H. Waldmann Max Planck Institut (MPI) für Molekulare Physiologie, Dortmund, Germany, H.H. Wasserman Lexington, MA, USA, R.M. Williams Colorado State University, Fort Collins, CO, USA, C.-H. Wong The Scripps Research Institute, La Jolla, CA, USA, J.L. Wood Colorado State University, Fort Collins, CO, USA, S.Z. Zard École Polytechnique, Palaiseau, France, Board of Consulting Editors K-H. Altmann Eidgenössische Technische Hochschule (ETH) Zürich, Zürich, Switzerland, P.S. Anderson , P.G. Baraldi Università di Ferrara, Ferrara, Italy, C. Barbas The Scripps Research Institute, La Jolla, CA, USA, J.K. Barton California Institute of Technology, Pasadena, CA, USA, C.R. Bertozzi University of California at Berkeley, Berkeley, CA, USA, B.S.J. Blagg University of Kansas, Lawrence, KS, USA, R. Breslow Columbia University, NY, USA, T.C. Bruice University of California at Santa Barbara, Santa Barbara, CA, USA, A.R. Chamberlin University of California at Irvine, Irvine, CA, USA, E.J. Corey Harvard University, Cambridge, MA, USA, B.F. Cravatt The Skaggs Institute of Chemical Biology, La Jolla, CA, USA, S. Danishefsky Memorial Sloan-Kettering Cancer Center, New York, NY, USA, P. Dervan California Institute of Technology, Pasadena, CA, USA, A. Eschenmoser Switzerland, D.M. Floyd Pharmacopeia Drug Discovery, Inc., Cranbury, NJ, USA, A. Giannis Universität Leipzig, Leipzig, Germany, B. Giese Université de Fribourg, Fribourg, Switzerland, P. Gmeiner Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany, H.B. Gray California Institute of Technology, Pasadena, CA, USA, G.L. Grunewald University of Kansas, Lawrence, KS, USA, P. Herrling Novartis Pharma AG, Basel, Switzerland, D. Hilvert Organic Chemistry Laboratory, Zurich, Switzerland, L.C. Hsieh-Wilson California Institute of Technology, Pasadena, CA, USA, W.L. Jorgensen Yale University, New Haven, CT, USA, J.A. Katzenellenbogen University of Illinois at Urbana-Champaign, Urbana, IL, USA, J. Kelly The Scripps Research Institute, La Jolla, CA, USA, P. Krogsgaard-Larsen University of Copenhagen, Copenhagen, Denmark, R. Lerner The Scripps Research Institute, La Jolla, CA, USA, H.-W. Liu University of Texas at Austin, Austin, TX, USA, L.A. Mitscher University of Kansas, Lawrence, KS, USA, K.C. Nicolaou The Scripps Research Institute, La Jolla, CA, USA, H.L. Pearce Eli Lilly and Company, Indianapolis, IN, USA, C.D. Poulter University of Utah, Salt Lake City, UT, USA, J. Rebek Jr The Scripps Research Institute, La Jolla, CA, USA, B. Samuelsson Karolinska Institutet, Stockholm, Sweden, S.L. Schreiber Harvard Business School, Cambridge, MA, USA, P.G. Schultz Howard Hughes Medical Instit
 
 
 
Shop with Confidence

Free Shipping around the world
▪ Broad range of products
▪ 30 days return policy
FAQ

Contact Us

Author Services

Prepare your Article for submission
Translation Services
English Language Editing
Illustrations

Celebrate your publication success
Article Offprints, Journal Issues, Article/Cover Posters, Create Your Own Book

Additional Services
Mobile Apps,Special Content Offerings,and more...